Office of Licensing & Ventures
| Diagnostic |
|---|
| Advanced Liquid Logic: nanoliter lab-on-a-chip powered by digital microfluidics. |
| Aldagen (formerly STEMCO Biomedical): products for the identification of adult stem cell populations with initial focus on the treatment of CV and peripheral artery disease. |
| Bioptigen: non-invasive optical coherence tomography for high-throughput, in vivo imaging of biological systems. |
| Centice: Computational sensing to facilitate the sampling of signals, such as an optical spectrum or image, with maximum efficiency and fidelity. |
| Expression Analysis: microarray-based genomic services for clinical trials. |
| Reproductive Health Technology: applying recently discovered technology to the diagnosis and treatments of women’s health concerns. |
| Drug Delivery |
| Affinergy: site specific biological delivery with binders that can selectively adhere to proteins, cells, and other biomaterial surfaces. |
| Merix Bioscience: RNA-based vaccine technology. Merix merged with Argos Therapeutics in 2004. |
| Phase Bioscience: products to deliver existing therapeutic agents with greater efficacy and lower side effects, and also manufacturing services for purification for therapeutic proteins and peptides. |
| Regado Biosciences: developing antidote-controlled therapeutics via simultaneous rational design of drug-antidote pairs. |
| Synergy Vaccines: research, development, and commercialization of novel vaccines using SynerVax™ adjuvant technology in order to provide more effective and less costly vaccines. |
| Hardware / Software / IT |
| Advanced Liquid Logic: nanoliter lab-on-a-chip powered by digital microfluidics. |
| Bright View Technologies: light management products for display applications. |
| MBright: a next-generation digital display technology company, winner of the Duke Startup Challenge in 2004. |
| Sentillion: enabling healthcare organizations to meet the challenges associated with identity and access management (IAM). |
| Therapeutics / BioTech |
| Angiomics: seed stage cancer therapy company with research focused on inhibiting new blood vessel growth. Assets acquired by Protein Design Labs in 2004. |
| Cellective Therapeutics: research on B-cells, a class of cells in the immune system. Acquired by MedImmune in 2005. |
| FibroGen: discovering, developing, and commercializing novel therapeutics for fibrotic disorders, diabetic complications, anemia, conditions associated with tissue damage or injury, cancer, and other areas of unmet medical need. |
| Humacyte: a development-stage company focused on the creation and commercialization of engineered human collagen-based products for several applications. |
| Nitrox: discovery and development of innovative strategies for treating disorders of oxygen delivery. |
| Precision Biosciences: Patent pending Directed Nuclease Editor(tm) allows production of enzymes capable of producing double-strand breaks at predetermined DNA sites, with a focus on anti-infective therapeutics. |
| Reproductive Health Technology: applying recently discovered technology to the diagnosis and treatments of women’s health concerns. |
Trimeris: Trimeris is a publicly traded company [TRMS] that discovers, develops, and commercializes treatments for viral diseases. |
| Trevena, Inc. is a drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs). |
| Therapeutics / Pharmaceutical |
| Aerie Pharmaceuticals: developing new therapies for sight-threatening diseases of the eye. |
| Bradmer: development and commercialization of cancer therapies with first product candidate targeting brain cancer. |
| MicroIslet: transplantation therapy for patients with diabetes that may enable diabetic patients to become free from insulin injections. |
| Orexigen: pharmaceutical products for the treatment of central nervous system disorders, with an initial focus on obesity. |
| Venture Services |
Southeast TechInventures STI: a technology accelerator for rapid conversion of university scientific breakthroughs into products, services and new technology companies. |
SyneCor: transforming innovative medical device ideas from concept through incubation into synergistic growth corporations. |